Compare LUV & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUV | MRNA |
|---|---|---|
| Founded | 1967 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.3B | 21.5B |
| IPO Year | 1995 | 2018 |
| Metric | LUV | MRNA |
|---|---|---|
| Price | $38.21 | $46.85 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 18 | 12 |
| Target Price | ★ $45.37 | $34.27 |
| AVG Volume (30 Days) | ★ 6.9M | 5.0M |
| Earning Date | 04-22-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.93% | N/A |
| EPS Growth | 3.95 | ★ 21.77 |
| EPS | ★ 0.45 | N/A |
| Revenue | N/A | ★ $19,263,000,000.00 |
| Revenue This Year | $16.57 | $9.36 |
| Revenue Next Year | $3.61 | $15.43 |
| P/E Ratio | $82.73 | ★ N/A |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $28.79 | $22.28 |
| 52 Week High | $55.11 | $59.55 |
| Indicator | LUV | MRNA |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 39.91 |
| Support Level | $38.09 | $23.52 |
| Resistance Level | $42.88 | $55.36 |
| Average True Range (ATR) | 1.47 | 2.69 |
| MACD | -0.13 | -0.90 |
| Stochastic Oscillator | 16.98 | 21.24 |
Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates nearly 800 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights operated in a single, open-seating cabin configuration in a point-to-point network. In early 2026, Southwest will modify its cabins to offer some rows with extra legroom and will update its ticketing process and merchandising to offer assigned seats and more fare categories, including a basic economy class that will more directly compete with other airlines' offerings and appear for the first time in travel aggregators' search results.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.